Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MGI Pharma and MethylGene begin phase II evaluation of MG-98 in head and neck cancer

Nov. 27, 2000

Significant activity seen for squalamine in phase II lung cancer trial

Nov. 27, 2000

Introgen's gene therapy shows significant proapoptotic activity in preclinical studies

Nov. 27, 2000

U.S. university researchers synthesize new heregulin antagonists based on rifamycin structure

Nov. 24, 2000

Anticancer platinum complexes designed at Unitech

Nov. 24, 2000

First potent and selective MMP-13 inhibitor discovered using structure-based design

Nov. 24, 2000

Preclinical profile of new Onyx-Bayer Ras pathway inhibitor described in detail at NCI-EORTC-AACR

Nov. 24, 2000

Onyvax raises funds to further its cancer vaccine programs

Nov. 24, 2000

CCI-779: a new rapamycin analogue targeting mTOR with a promising clinical profile

Nov. 23, 2000

Sulfonamide-based MMP inhibitors in development at Shionogi

Nov. 22, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...